-
Mashup Score: 10Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review - 10 day(s) ago
Quality of Life Research – The time to deterioration (TTD) approach has been proposed as a modality of longitudinal analysis of patient-reported outcomes (PROs) in cancer randomized clinical trials…
Source: link.springer.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 8
Alliance A021501 is the first randomized trial to evaluate stereotactic body radiation therapy (SBRT) for borderline resectable pancreatic ductal adenocarcinoma (PDAC) after neoadjuvant chemotherapy. In this post hoc study, we reviewed the quality of radiation therapy (RT) delivered.
Source: www.redjournal.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4
Alliance A021501 is the first randomized trial to evaluate stereotactic body radiation therapy (SBRT) for borderline resectable pancreatic ductal adenocarcinoma (PDAC) after neoadjuvant chemotherapy. In this post hoc study, we reviewed the quality of radiation therapy (RT) delivered.
Source: www.redjournal.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2RP240233 — Cancer Prevention and Research Institute of Texas - 2 month(s) ago
Texans voted in 2007 to create the Cancer Prevention & Research Institute of Texas (CPRIT) and to invest $3 billion in the state’s unprecedented fight against cancer. On November 5, 2019, Texas voters overwhelmingly approved a constitutional amendment to continue CPRIT’s work and invest an additional $3 billion for finding and funding the best cancer research and prevention opportunities in the state. CPRIT is now a $6 billion, 20-year initiative – the largest state cancer research investment in the history of the United States and the second largest cancer research and prevention program in the world.
Source: www.cprit.state.tx.usCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 10A Story of Hypofractionation and the Table on the Wall - 2 month(s) ago
I was recently informed that I won a contest that I did not actually enter. A Twitter poll was organized through @Radiation Nation inspired by Sue Yom, the new editor of the journal, asking, “What do people consider the gold standard for treatment planning for hypofractionated RT?” Response options were “HyTEC; AAPM TG-101; Timmerman Sheet; and NRG/RTOG protocols.” With just over 100 total votes in 24 hours, “Timmerman Sheet,” which at University of Texas Southwestern we call our “constraint tables,” won with 37.5% of votes.
Source: www.redjournal.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 112Optimizing Risk Vs. Reward in the Era of Ablative Radiotherapy Through Calculated Useful Trauma (CUT) - 2 month(s) ago
Author links open overlay panel Nina N. Sanford MD, Robert D. Timmerman MD There are more references available in the full text version of this
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4
There is no specific guideline for the treatment of locally advanced rectal cancers in the elderly. Here we compared R0 resection rate and degradation…
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 8
In 2023, the Common Sense Oncology (CSO) movement was launched with the goal of recalibrating cancer care to focus on outcomes that matter to patients…
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 8
In 2023, the Common Sense Oncology (CSO) movement was launched with the goal of recalibrating cancer care to focus on outcomes that matter to patients…
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 173Need for Evidence-Based Adoption of New Technologies in Radiotherapy - 3 month(s) ago
This Viewpoint discusses the need for multi-institutional prospective randomized trials of new technologies in radiotherapy to improve the therapeutic ratio and safety of radiotherapy treatments.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet
Challenge is how to define deterioration. Thanks to @AnkerUVMRadOnc for finding this review for me. Welcome any other thoughts. https://t.co/pQqf3XpZsR